CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


gammaCore® (Vagus nerve stimulation)Wiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D012818 Signs and Symptoms, Respiratory NIH 0.50

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 A Prospective, Randomized, Controlled Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms (SAVIOR)

The purpose of this study is to asses the efficacy of the Gammacore device reducing the need for mechanical ventilation in patients diagnosed of Covid-19

NCT04368156 Covid-19 Device: gammaCore® (Vagus nerve stimulation)
MeSH:Signs and Symptoms, Respiratory

Primary Outcomes

Measure: Need for mechanical ventilation

Time: From randomization to hospital discharge or ICU admission, whatever occurs first, assessed up to two months

Secondary Outcomes

Measure: Supplemental oxygen requirements

Time: From randomization to hospital discharge or ICU admission, whatever occurs first, assessed up to two months

Measure: Mortality

Time: From randomization to hospital discharge or ICU admission, whatever occurs first, assessed up to two months

Measure: Delay onset of ventilation

Time: From randomization to the day of need for mechanical ventilation or hospital discharge, whatever occurs first, assessed up to two months

Measure: Cytokine levels

Time: From randomization to hospital discharge or ICU admission, whatever occurs first, assessed up to two months


No related HPO nodes (Using clinical trials)